Atlantic Coastal Acquisition II to Combine with 03 Life Sciences
Ticker: ABPWW · Form: 8-K · Filed: May 17, 2024 · CIK: 1893219
| Field | Detail |
|---|---|
| Company | Atlantic Coastal Acquisition CORP. II (ABPWW) |
| Form Type | 8-K |
| Filed Date | May 17, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: spac, acquisition, biotechnology
TL;DR
SPAC deal incoming: Atlantic Coastal Acquisition II is merging with biotech firm 03 Life Sciences.
AI Summary
Atlantic Coastal Acquisition Corp. II announced on May 16, 2024, that it has entered into a definitive agreement to combine with 03 Life Sciences. This SPAC is focused on the biotechnology sector and will merge with the company, which is involved in biological products. The filing does not specify any dollar amounts or exact closing dates for the transaction.
Why It Matters
This SPAC merger signals a new investment opportunity in the biotechnology sector, potentially bringing 03 Life Sciences to the public markets.
Risk Assessment
Risk Level: medium — SPAC mergers carry inherent risks related to deal completion, valuation, and the future performance of the combined entity.
Key Players & Entities
- Atlantic Coastal Acquisition Corp. II (company) — Registrant
- 03 Life Sciences (company) — Target company for combination
- May 16, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the business of 03 Life Sciences?
03 Life Sciences is involved in biological products, as indicated by the SIC code for Biological Products (No Diagnostic Substances).
What is the filing date of this 8-K?
This 8-K was filed on May 17, 2024.
What is the primary purpose of this 8-K filing?
The primary purpose is to report an 'Other Event', specifically the definitive agreement to combine with 03 Life Sciences.
What is the state of incorporation for Atlantic Coastal Acquisition Corp. II?
Atlantic Coastal Acquisition Corp. II is incorporated in Delaware.
What are the business address and phone number listed for Atlantic Coastal Acquisition Corp. II?
The business address is 6 St Johns Lane, Floor 5, New York, NY 10013, and the phone number is 248-890-7200.
Filing Stats: 488 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-05-17 16:05:22
Key Financial Figures
- $0.0001 — of one share of Series A common stock, $0.0001 par value, and one-half of one redeemab
- $11.50 — A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC
Filing Documents
- d839980d8k.htm (8-K) — 26KB
- 0001193125-24-141711.txt ( ) — 186KB
- acab-20240516.xsd (EX-101.SCH) — 3KB
- acab-20240516_def.xml (EX-101.DEF) — 14KB
- acab-20240516_lab.xml (EX-101.LAB) — 23KB
- acab-20240516_pre.xml (EX-101.PRE) — 15KB
- d839980d8k_htm.xml (XML) — 7KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 ATLANTIC COASTAL ACQUISITION CORP. II (Exact name of registrant as specified in its charter) Delaware 001-41224 87-1013956 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6 St Johns Lane, Floor 5 New York , NY 10013 (Address of principal executive offices) (Zip Code) ( 248 ) 890-7200 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Units, each consisting of one share of Series A common stock, $0.0001 par value, and one-half of one redeemable warrant ACABU The Nasdaq Stock Market LLC Shares of Series A common stock included as part of the units ACAB The Nasdaq Stock Market LLC Warrants included as part of the units, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item8.01 Other Events. On May 16, 2024, Atlantic Coastal Acquisition Corp. II (the "Company"), by resolution of the board of directors of the Company, in accordance with the Company's Amended and Restated Certificate of Incorporation (as amended), extended the expiration date of the amount of time that the Company has available to complete a business combination from May 19, 2024 to June 19, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 17, 2024 ATLANTIC COASTAL ACQUISITION CORP. II By: /s/ Shahraab Ahmad Shahraab Ahmad Chief Executive Officer